This small cap company signed MoU with a Global Manufacturer of Electrolytes; Stock up by 10 per cent in two sessions!
This small cap company signed MoU with a Global Manufacturer of Electrolytes; Stock up by 10 per cent in two sessions!
The company's foray into electrolyte manufacturing complements the government's Make in India initiative
The company's foray into electrolyte manufacturing complements the government's Make in India initiative.
This multibagger microcap stock receives a fresh order of Rs 6,64,00,000 - Do you own it?
This multibagger microcap stock receives a fresh order of Rs 6,64,00,000 - Do you own it?
The stock has given 312 per cent return in 3 years!
The stock has given 312 per cent return in 3 years!
This under-the-radar micro-cap pharma stock hits upper circuit on record volume, do you hold?
This under-the-radar micro-cap pharma stock hits upper circuit on record volume, do you hold?
The Stock hit the upper circuit today at Rs. 68.01, driven by an impressive 17.89 times surge in trading volume
Vineet Laboratories Ltd experienced a substantial upswing, hitting the upper circuit at Rs. 68.01, driven by an impressive 17.89 times surge in trading volume. The trading floor buzzed with activity as 1,87,011 units changed hands during this dynamic session.
Promoters and FIIs increased stake: This small-cap pharma company targeted Rs 750 crore revenue!
Promoters and FIIs increased stake: This small-cap pharma company targeted Rs 750 crore revenue!
The company plans to launch several new products in the domestic and export markets in Q3 and Q4 of FY24.
FII stake increase: Foreign Institutional Investors (FIIs) have increased their stake in Lincoln Pharma from 0.63 per cent in September 2022 to 2.59 per cent in September 2023.
Promoter holding increase: The promoter holding in Lincoln Pharma has also increased from 44.09 per cent in September 2022 to 50.53 per cent in September 2023.
Stellar performance: Q1FY24 net profit skyrockets by 100 per cent; pharma stock hits back-to-back 52-week high!
Stellar performance: Q1FY24 net profit skyrockets by 100 per cent; pharma stock hits back-to-back 52-week high!
The stock has experienced significant buying activity, soaring by over 70 per cent in the past 1 year.
Overall, Trident Lifeline Limited's Q1FY24 financial performance demonstrates its strong market position and ability to capitalize on growth opportunities in the pharmaceutical industry.
This pharmaceutical company establishes a record date for the dividend!
This pharmaceutical company establishes a record date for the dividend!
The company has delivered returns of 22 per cent over the past year and great returns of 110 per cent over the past 3 years.
On Monday, shares of the company surged by 0.56 per cent to trade at Rs 1,041.25.
52-week high alert: This pharmaceutical company stock surges on getting USFDA’s approval for new drug!
52-week high alert: This pharmaceutical company stock surges on getting USFDA’s approval for new drug!
This drug had estimated annual sales of USD 262 million in the US.
This drug had estimated annual sales of USD 262 million in the US.
52-week high alert: This small-cap pharma company share surged over 6 per cent, do you have it?
52-week high alert: This small-cap pharma company share surged over 6 per cent, do you have it?
Shares of the company saw a spurt in volume by more than 2.67 times on BSE.
Shares of the company saw a spurt in volume by more than 2.67 times on BSE.
This pharmaceutical company recommended 1500 per cent dividend for FY23!
This pharmaceutical company recommended 1500 per cent dividend for FY23!
As the season of financial results is on the company has reported numbers; stock surged by 4.25 per cent today.
As the season of financial results is on the company has reported numbers; stock surged by 4.25 per cent today.
Multibagger stock below Rs 250: Don't miss action in this stock that has announced rights issue!
Multibagger stock below Rs 250: Don't miss action in this stock that has announced rights issue!
The stock has returned 71.50 per cent year to date and in just one year, it has generated multibagger gains of 224.16 per cent.
The stock has returned 71.50 per cent year to date and in just one year, it has generated multibagger gains of 224.16 per cent.
Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!
Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!
The only sector which was least affected today was the BSE Healthcare Index, which plunged 1.18 per cent to Rs 23,493.96, despite a sharp decline in the domestic market.
The only sector which was least affected today was the BSE Healthcare Index, which plunged 1.18 per cent to Rs 23,493.96, despite a sharp decline in the domestic market.
This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it?
This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it?
The company is ranked among the world’s top 100 biopharmaceutical companies and among the world’s top 50 companies in the off-patent sector.
Glenmark Pharmaceuticals Ltd is an innovation-driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses